CBD clinical trials at UCSD

• Efficacy of Inhaled Cannabis for Acute Migraine Treatment

  open to eligible people ages 21-65

  This crossover study will evaluate 3 different treatments of vaporized cannabis (THC, THC/CBD mix, and CBD) and vaporized placebo cannabis for the acute treatment of migraine.

  La Jolla, California

Last updated: November 20, 2020